$MNST

Monster Beverage downgraded to Hold as valuation seen limiting further upside By Investing.com

Deutsche Bank downgraded Monster Beverage (MNST) to Hold from Buy, citing valuation limits after the stock’s outperformance. The firm raised its price target to $98 from $98, implying about 1% upside. It said fundamentals remain strong, with risks tied to category growth, retail sales, international expansion, pricing, and margins.

Original reporting
Published Jul 20, 2026, 1:14 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 20, 2026, 1:30 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefFinancial news
Primary signal
$MNST
Bearish
medium confidence
Mentioned
$MNST
Relevance
7/10
alphai data visualization · based on investing.com
Decision brief

The 30-second read

$MNSTBearishMed
01

Why it matters

A Hold downgrade with a low implied upside can reduce incremental demand from valuation-driven investors and increase sensitivity to any negative surprises in category growth, retail trends, international expansion, pricing, or margins.

02

Market read

Traders get a concrete sentiment and positioning input: a valuation-based downgrade that signals limited upside unless results beat optimistic expectations.

03

What to watch

The article notes the target was raised to $98, which can partially offset the downgrade; traders should watch whether the market already priced the valuation risk into the recent rally.

Relevance 7/10Novelty 6/10Timing: today, following the analyst downgrade and revised price target

Background

The piece frames the move as valuation risk after MNST’s recent outperformance, not deterioration in business fundamentals.

Company-level read

Ticker impact

$MNSTBearishMedium confidence
Context

Deutsche Bank downgraded Monster Beverage to Hold from Buy, citing valuation that leaves only about 1% upside despite strong execution.

Expected impact

Near-term downside bias or underperformance versus peers until the stock re-rates or new results exceed already-optimistic expectations.

Evidence & confidence

The article’s actionable change is the rating cut and the implied limited upside from the raised $98 target, which typically weighs on momentum traders and valuation-sensitive positioning.

Market effects

Valuation caution from a major bank can spill over to other energy drink names if investors treat it as a read-across on category multiples.

No specific regional transmission beyond global demand commentary for energy drinks.

Limited global relevance; the catalyst is company-specific (MNST rating change) rather than a broad macro shock.

Counterpoint

If MNST’s operational momentum and fiscal 2026-2027 forecasts above consensus hold, the Hold rating may be less important than upcoming results that can force a re-rating.

Key entities

  • Monster Beverage

    Energy drink maker whose rating was cut to Hold from Buy by Deutsche Bank.

  • Deutsche Bank

    Brokerage issuing the downgrade and raising the price target to $98.

Related articles

$PEPMed

International Business: India ‘won’t extend’ energy drink label deadline

India’s food safety regulator FSSAI will not extend a 90-day deadline to remove “energy drink” or similar labels from high-caffeine beverages, a government source said. PepsiCo, Red Bull, Monster Beverage and Reliance are seeking up to one year, citing inventory and pending imports. FSSAI says the term breaches rules and states can sell existing stock in 60-90 days.

$MNSTMed

Morgan Stanley Lifts Monster Beverage Target to $110, Sees More Upside Ahead — BigGo Finance

Morgan Stanley raised its Monster Beverage (MNST) price target to $110 from $103 and reiterated an Overweight rating, implying about 9% upside versus current levels, according to the bank. FactSet shows analysts average an Overweight rating and a mean target of $100.70. Investors may look to upcoming quarterly results for volume, pricing, and margin trends.

$MNSTMed

Monster (NASDAQ:MNST) Surprises With Q2 CY2026 Sales

Monster Beverage (NASDAQ: MNST) reported Q2 CY2026 sales of $2.54 billion, up 20.2% year on year, topping Wall Street revenue expectations by 4.1%. Non-GAAP profit was $0.60 per share, about 3% above consensus. The article notes trailing 12-month revenue of $9.22 billion and a free cash flow margin averaging 24.4% over two years.

$MNSTMedAI 9/10

Monster Beverage Corp (MNST): Results of Operations and Financial Condition

Monster Beverage Corp (MNST) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 tm2622396d1_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Investor Relations Strategic Public Relations PondelWilkinson Inc. 2945 Townsgate Road, Suite 200 Westlake Village, CA 91361 T (310) 279 5980 W www.pondel.com CONTACTS: NEWS RELEASE Mark Astrachan SVP, Investor Relations

$MNSTMed

Morgan Stanley unveils key Monster stock price prediction

Morgan Stanley reiterated an Overweight rating and $103 price target on Monster Beverage (MNST), citing new product launches. Morgan said new items rose to nearly 15% of Monster’s US retail sales from about 3.5% end-2025 and zero in September. Monster reported Q1 2026 net sales up 26.9% to $2.35B and authorized a $500M buyback; gross margin slipped to 55% from 56.5%.